Positron Emission Tomography/Computed Tomography

89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

Biomarkers to Detect Endocrine Therapy Resistance

[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma

Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer

PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer

68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer

The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer

Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

Brivanib Metastatic Renal Cell Carcinoma

PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors

18F-FLT PET Imaging in Patients With Advanced Melanoma

Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer

Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC

MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma

Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer

PET/CT Scan-Guided Watchful Waiting or Neck Dissection of Locally Advanced Lymph Node Metastases in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Primary Head And Neck Cancer